Clinical Trials Directory

Trials / Completed

CompletedNCT00863954

Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes

A Controlled Pilot Study of the Application of Magnetic Fields Using the Resonator in Adjunctive Management of Type 2 Diabetes

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
pico-tesla Magnetic Therapies, LLC · Industry
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to see if using a device called the Resonator, that puts out a very low electromagnetic field, effects blood glucose and A1c levels in people with Type 2 Diabetes.

Detailed description

The purpose of this pilot study is to determine whether application of magnetic fields generated by the Resonator result in statistically significant reductions in finger stick blood glucose levels, serum glucose and hemoglobin A1c levels. The study will also investigate any induced changes in serum lipids and liver function tests as indirect markers of insulin resistance.

Conditions

Interventions

TypeNameDescription
DEVICEResonator Devicecomparison of different parameter settings of electromagnetic fields using the Resonator Device

Timeline

Start date
2009-01-01
Primary completion
2009-11-01
Completion
2009-11-01
First posted
2009-03-18
Last updated
2010-12-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00863954. Inclusion in this directory is not an endorsement.

Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes (NCT00863954) · Clinical Trials Directory